What is the recommended dose of sumatriptan (triptan) for migraine treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sumatriptan Dosing for Migraine Treatment

The recommended dose of oral sumatriptan for migraine treatment is 50 mg initially, which may be increased to 100 mg if needed, with a maximum daily dose of 200 mg in a 24-hour period. 1

Dosing Options by Route of Administration

Oral Administration

  • Initial recommended dose: 25 mg, 50 mg, or 100 mg 1
  • 50 mg and 100 mg doses provide greater efficacy than 25 mg, though 100 mg may not provide additional benefit over 50 mg 1
  • Maximum daily dose: 200 mg in a 24-hour period 1
  • If migraine persists after 2 hours or returns after initial improvement, a second dose may be administered (at least 2 hours after first dose) 1

Subcutaneous Administration

  • Recommended dose: 6 mg SC, which can be repeated after one hour 2
  • Maximum daily dose: 12 mg per 24 hours 2
  • Provides fastest relief (peak blood concentration in approximately 15 minutes) 2
  • Most effective route with 59% of patients achieving pain-free status at 2 hours 3

Intranasal Administration

  • Recommended dose: 5-10 mg (one to two sprays) in one nostril 2
  • May be repeated after 2 hours 2
  • Maximum daily dose: 40 mg per day 2

Efficacy Considerations

  • The 50 mg oral dose offers the best balance of efficacy and tolerability 4
  • Subcutaneous administration provides more rapid pain relief than other routes 3
  • Taking medication early when pain is mild is more effective than waiting until pain is moderate or severe 3
  • Effectiveness rates for headache relief at 2 hours:
    • Oral 100 mg: NNT 3.5 3
    • Subcutaneous 6 mg: NNT 2.1 (most effective) 3
    • Intranasal 20 mg: NNT 3.5 3

Special Dosing Considerations

  • For patients with mild to moderate hepatic impairment, maximum single dose should not exceed 50 mg 1
  • If a patient experiences unpleasant sensory disturbances with one triptan, trying a different triptan may be beneficial 5
  • Patients should try a medication for 2-3 headache episodes before abandoning that line of therapy 2, 5

Important Contraindications

  • Ergotamine use (do not use within 24 hours of each other) 2
  • MAOIs 2
  • Use within 24 hours of another triptan 2
  • Hemiplegic or basilar migraine 2
  • Pregnancy 2
  • Impaired hepatic function (dose adjustment required) 2
  • Coronary artery disease 2

Common Adverse Effects

  • Oral administration: nausea, vomiting, malaise, fatigue, dizziness 6
  • Subcutaneous administration: injection site reactions (in approximately 30% of patients), chest pressure and heaviness 2, 6
  • Adverse events are generally mild to moderate and of short duration 3
  • Higher incidence of adverse events with 100 mg (30%) compared to 50 mg (21%) and 25 mg (19%) 7

Clinical Pearls

  • If using after sumatriptan injection, additional single tablets (up to 100 mg/day) may be given with an interval of at least 2 hours between doses 1
  • The safety of treating more than 4 headaches in a 30-day period has not been established 1
  • Recurrence rates are similar across different oral doses (33-38%), though higher doses may delay recurrence time 7
  • Patient preference studies show that 35% prefer 100 mg, 31% prefer 50 mg, and 25% prefer 25 mg, with efficacy and speed of action being the main reasons for preferring higher doses 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.